Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.84 |
| ▸ | CHAT | P28329 | 2/20 | 0.80 |
| ▸ | EP300 | Q09472 | 4/20 | 0.79 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.79 |
| ▸ | AURKA | O14965 | 2/20 | 0.79 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.79 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL29353902 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL20505754 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL12303241 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL29371268 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL4358590 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL1198 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL22277142 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL21067504 | 1.00 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL6382909 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A SCHEMBL5497515 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2124 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | AMYRIS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-3608338-B1 | HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR | REGENERON PHARMA (US) | 2026-03-11 | — | — | EP | claimed |
| US-12497635-B2 | Means and methods for producing isobutene from acetyl-CoA | GLOBAL BIOENERGIES (FR) | 2025-12-16 | — | — | US | claimed |
| US-12486513-B2 | Modulation of carbon flux through the meg and C3 pathways for the improved production of monoethylene glycol and C3 compounds | BRASKEM S.A. (BR) | 2025-12-02 | — | — | US | claimed |
| US-12460234-B2 | Synthesis of isoprenoids and derivatives | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-11-04 | — | — | US | claimed |
| US-20250327097-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2025-10-23 | — | — | US | claimed |
| US-20250304704-A1 | HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR | REGENERON PHARMA (US) | 2025-10-02 | — | — | US | claimed |
| US-20250263758-A1 | A CELL-FREE BIO-MANUFACTURING PLATFORM FOR PRODUCTION OF FATTY ACIDS AND CANNABINOIDS | UNITED STATES DEPARTMENT OF ENERGY | 2025-08-21 | — | — | US | claimed |
| CN-114746415-B | Polymorphs of triazole antifungal compound PC945 | 普尔莫赛德有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2010039536-A2 | SIRT4 AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-04-08 | — | — | WO | claimed |
| EP-2166843-A2 | TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2010-03-31 | — | — | EP | claimed |
| US-7622282-B2 | Biosynthesis of isopentenyl pyrophosphate | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-11-24 | — | — | US | claimed |
| WO-2009064910-A2 | DIMETHYLOCTANE AS AN ADVANCED BIOFUEL | SYNTHETIC GENOMICS, INC. (US) | 2009-05-22 | — | — | WO | claimed |
| EP-1896074-A4 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING CORONARY ARTERY DISEASE | LIPONEX INC (CA) | 2009-04-22 | — | — | EP | claimed |
| WO-2009023059-A2 | TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2009-02-19 | — | — | WO | claimed |
| EP-1896074-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING CORONARY ARTERY DISEASE | Liponex, Inc. (CA) | 2008-03-12 | — | — | EP | claimed |
| US-20070269503-A1 | Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof | IMASIGHT INC. (CA) | 2007-11-22 | — | — | US | claimed |
| US-20060275356-A1 | Pharmaceutical compositions for treating or preventing coronary artery disease | LIPONEX INC. (CA) | 2006-12-07 | — | — | US | claimed |
| WO-2006125304-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING CORONARY ARTERY DISEASE | LIPONEX, INC. (CA) | 2006-11-30 | — | — | WO | claimed |